Filter
1594
Filtered Results: 1594
Text search:
COVID
testing
Featured
Recommendations
250
New Publications
28
Language
Document type
Studies & Reports
491
Guidelines
489
Fact sheets
151
Strategic & Response Plan
149
Manuals
134
Situation Updates
58
Training Material
34
No document type
24
Infographics
23
Resource Platforms
20
Brochures
10
Online Courses
7
Videos
2
Dashboards/Maps
1
App
1
Countries / Regions
Global
114
Germany
60
India
53
Africa
51
Western and Central Europe
45
Latin America and the Carribbean
40
East and Southern Africa
38
South Africa
38
Russia
36
Syria
34
West and Central Africa
34
Brazil
34
Middle East and North Africa
33
Kenya
24
Ukraine
24
Yemen
22
Eastern Europe and Central Asia
21
Ethiopia
20
South–East Asia Region
19
Bangladesh
16
South Sudan
14
Mozambique
13
Colombia
12
Malawi
12
Western Pacific Region
12
Nigeria
11
Peru
11
Ghana
10
Congo, Democratic Republic of
9
Somalia
9
Angola
8
Zambia
8
Myanmar / Burma
8
Sierra Leone
7
Chile
7
Senegal
7
Afghanistan
7
Philippines
7
Venezuela
7
Uganda
7
Eastern Europe
7
Rwanda
6
Spain
6
Argentina
6
Sudan
6
Palestine
6
Liberia
6
Ecuador
6
Pakistan
6
Zimbabwe
5
Bolivia
5
Lebanon
5
Vietnam
5
Moldova
5
Iraq
5
Nepal
4
Mexico
4
El Salvador
4
Laos
4
Guinea-Bissau
4
Jordan
4
United Kingdom
4
Côte d’Ivoire / Ivory Coast
4
Chad
4
Turkey
3
China
3
Cameroon
3
Burkina Faso
3
Italy
3
Haiti
3
Cambodia
3
Tanzania
3
Portugal
3
Sri Lanka
3
Djibouti
3
Egypt
3
Central African Republic
3
Mali
3
Timor Leste/ East Timor
2
Kazakhstan
2
Niger
2
Burundi
2
Bulgaria
2
USA
2
Hungary
2
Saudi Arabia
2
North America
2
Jamaica
2
Mauritius
2
Tunisia
2
Papua New Guinea
2
Nicaragua
2
Romania
2
Poland
2
Honduras
2
Libya
2
Eswatini/ Swaziland
2
North Korea
1
Thailand
1
Lesotho
1
Australia
1
Togo
1
Iran
1
Morocco
1
Guinea
1
Armenia
1
Asia
1
Dominican Republic
1
Ireland
1
Paraguay
1
Gabon
1
Turkmenistan
1
France
1
Morocco
1
Belarus
1
French Guyana
1
Israel
1
Namibia
1
Slovakia
1
Greece
1
Bhutan
1
Botswana
1
Indonesia
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
668
Clinical Guidelines
75
Public Health
70
Key Resources
62
Women & Child Health
39
Pharmacy & Technologies
28
Capacity Building
14
Annual Report MEDBOX
1
Toolboxes
COVID-19
949
HIV
77
Refugee
50
TB
50
Conflict
47
Rapid Response
45
Planetary Health
40
Caregiver
38
Health Financing Toolbox
30
AMR
29
NCDs
28
NTDs
27
Mental Health
19
Pharmacy
16
Global Health Education
14
Natural Hazards
11
Disability
10
Ebola & Marburg
7
Malaria
5
Cholera
3
Zika
3
Polio
2
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
Community use of face masks
recommended
Update 1 October 2020.
This document provides guidance to Member States on the effective use of face masks/coverings in the community by individuals without COVID-19 symptoms in order to reduce potential transmission of SARS-CoV-2.a It also provides advice on the use of masks during home care for ...
The WHO Health Emergencies Programme is currently monitoring 118 events in the region. This week’s main articles cover the following events:
Coronavirus disease 2019 (COVID-19) in Togo
Measles in Chad
Ebola virus disease (EVD) in Équateur Province, Democratic Republic of the Congo.
This joint publication by UNAIDS and WHO emphasizes the importance of integrating HIV prevention, testing, treatment and care and mental health services for people living with HIV. It provides a compilation of tools, best practices, recommendations and guidelines that facilitate the integration of i...
September – December 2021
The funds will be used by WHO to ensure:
continued coordination with other agencies and health actors in the response to the crisis situation
continuity of health services for the population of Afghanistan
provision of life-saving medical supplies
con...
N95 or equivalent respirators are single-use personal protective equipment (PPE) designed for use by health workers that provide direct care to patients with diseases transmitted by aerosols or during aerosol generating procedures (AGP) for patients with acute respiratory disease, as is the case of ...
BMJ Global Health2020;5:e002914. doi:10.1136/bmjgh-2020-002914
The evidence produced in mathematical models plays a key role in shaping policy decisions in pandemics. A key question is therefore how well pandemic models relate to their implementation contexts. Drawing on the cases of Ebola and in...
3 June 2021. After 40 years of AIDS, charting a course to end the pandemic.
The report shows that countries with progressive laws and policies and strong and inclusive health systems have had the best outcomes against HIV. In those countries, people living with and affected by HIV are more likely t...
Every year, nearly 250 million people move across borders temporarily or permanently for a job opportunity, studying, to flee a crisis back home, or for other reasons. Another 750 million move for similar reasons within the borders of their countries. With the understanding that human mobility affec...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
WHO Guideline on self-care interventions for health and well-being, 2022 revision: executive summary
recommended
A global shortage of an estimated 18 million health workers is anticipated by 2030, a record 130 million people are in need of humanitarian assistance, and there is the global threat of pandemics such as COVID-19. At least 400 million people worldwide lack access to the most essential health service...
The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consideration the lessons learned from the response to t...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
Language influences the way we think, how we perceive reality, and how we behave. With respect to HIV, language can embody stigma and discrimination, which impacts access to testing, acquisition of HIV, and engagement with treatment. Language plays a role in supporting respect and empowerment of ind...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
Occupational health and safety programmes aim to prevent diseases and injuries arising out of, linked with or occurring in the course of work, while improving the quality and safety of care, safeguarding the health workforce and promoting environmental sustainability in the health sector.
This gu...
Objectifs 2020 : des avancées disparates. Le rapport de l’ONUSIDA sur l’épidémie mondiale de sida fait état d’un échec accentué par la COVID-19. Depuis 2015, 3,5 millions d’infections au VIH et 820 000 morts supplémentaires liés au sida sont imputables à des objectifs non atteints. ...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
This training module is designed to equip HWs with knowledge and communication skills to build their confidence and support them in their ability to promote acceptance of COVID-19 vaccination among other HWs.
Los coronavirus son un grupo de virus ARN altamente diversos de la familia Coronaviridae que se dividen en
4 géneros: alfa, beta, gamma y delta, y que causan enfermedades de leves a graves en humanos y animales
(1-3). Existen coronavirus humanos endémicos como los alfacoronavirus 229E y NL63 y l...
